查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2153484

全球血液篩檢市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Blood Screening Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球血液篩檢市場預計將從2025年的38.8億美元成長至2034年的113.1億美元，並預計在2026年至2034年間以12.62%的複合年成長率成長。受感染疾病蔓延和對安全輸血需求不斷成長的推動，血液篩檢市場預計將顯著成長。血液篩檢是確保血液製品安全的關鍵流程，其作用在於檢測病原體、抗體和其他有害物質。隨著醫療機構將病患安全放在首位，監管機構也提出了更嚴格的檢測要求，預計先進血液篩檢技術的應用將會增加。該市場正朝著更有效率、更準確的檢測方法轉變，例如核酸檢測（NAT）和多重檢測，這些方法提高了血液篩檢的檢測能力。

此外，血液篩檢技術的進步正在推動市場創新。自動化系統和即時檢測解決方案的開發正在改變血液篩檢的方式，從而實現更快的檢測結果和更有效率的工作流程。這些創新不僅提高了檢測的準確性，還縮短了出結果的時間，使醫護人員能夠及時做出有關患者照護的決策。隨著血液篩檢市場的不斷發展，持續的研發工作將在拓展可用檢測解決方案的範圍以滿足醫護人員多樣化的需求方面發揮關鍵作用。

此外，人們對預防醫學和早期檢測的日益重視也在影響血液篩檢的發展趨勢。隨著人們對定期體檢重要性的認知不斷提高，患者越來越傾向於進行血液檢測，以便在健康問題變得嚴重之前發現潛在隱患。醫療專業人員也逐漸認知到主動篩檢在慢性病管理和改善患者預後的價值。隨著血液篩檢市場的持續成長，技術進步、患者意識的提高以及對預防醫學的重視將在推動未來成長方面發揮關鍵作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球血液篩檢市場：依技術分類

  • 市場分析、洞察與預測
  • 核酸增幅檢查（NAT）
  • ELISA
  • 化學冷光免疫檢測（CLIA 和 EIA）
  • 次世代定序（NGS）
  • 蛋白質印跡法（WB）

第5章 全球血液篩檢市場：依產品分類

  • 市場分析、洞察與預測
  • 試劑
  • 裝置

第6章 全球血液篩檢市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Grifols
    • Abbott
    • Roche Diagnostics
    • Danaher
    • Bio-Rad Laboratories
    • DiaSorin
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • Hologic
    • BioMerieux
    • Ortho Clinical Diagnostics
    • Fujirebio
    • Sysmex
    • Werfen
    • Beckman Coulter
    • Becton Dickinson
    • QuidelOrtho
    • Meridian Bioscience
    • Luminex
    • Gen-Probe
簡介目錄
Product Code: VMR11210532

The global blood screening market size is expected to reach USD 11.31 Billion in 2034 from USD 3.88 Billion in 2025, growing at a CAGR of 12.62% during 2026-2034.The blood screening market is poised for significant growth, driven by the increasing prevalence of infectious diseases and the rising demand for safe blood transfusions. Blood screening is a critical process that ensures the safety of blood products by detecting pathogens, antibodies, and other harmful substances. As healthcare providers prioritize patient safety and regulatory bodies enforce stringent testing requirements, the adoption of advanced blood screening technologies is expected to rise. This market is witnessing a shift towards more efficient and accurate testing methods, including nucleic acid testing (NAT) and multiplex assays, which enhance the detection capabilities of blood screening processes.

Moreover, advancements in blood screening technologies are propelling innovation within the market. The development of automated systems and point-of-care testing solutions is transforming the way blood screening is conducted, allowing for faster results and improved workflow efficiency. These innovations not only enhance the accuracy of testing but also reduce the turnaround time for results, enabling healthcare providers to make timely decisions regarding patient care. As the blood screening market continues to evolve, ongoing research and development efforts will play a crucial role in expanding the range of testing solutions available to meet the diverse needs of healthcare providers.

Additionally, the growing emphasis on preventive healthcare and early detection is shaping the blood screening landscape. As awareness of the importance of regular health screenings increases, patients are more likely to seek out blood tests that can identify potential health issues before they escalate. Healthcare providers are also recognizing the value of proactive screening in managing chronic conditions and improving patient outcomes. As the blood screening market continues to grow, the combination of technological advancements, increasing patient awareness, and a focus on preventive care will play a crucial role in driving its future growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

  • Nucleic Acid Amplification Test (NAT)
  • ELISA
  • Chemiluminescence Immunoassay (CLIA & EIA )
  • Next Generation Sequencing (NGS)
  • Western Blotting (WB)

By Product

  • Reagent
  • Instrument

COMPANIES PROFILED

  • Grifols, Abbott, Roche Diagnostics, Danaher, Bio-Rad Laboratories, DiaSorin, Siemens Healthineers, Thermo Fisher Scientific, Hologic, bioMerieux, Ortho Clinical Diagnostics, Fujirebio, Sysmex, Werfen, Beckman Coulter, Becton Dickinson, QuidelOrtho, Meridian Bioscience, Luminex, Gen-Probe

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Nucleic Acid Amplification Test (NAT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Chemiluminescence Immunoassay (CLIA & EIA ) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Next Generation Sequencing (NGS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Western Blotting (WB) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Reagent Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Instrument Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD SCREENING MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Technology
    • 6.2.2 By Product
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Technology
    • 6.3.2 By Product
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Spain
    • 6.3.8 Russia
    • 6.3.9 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Technology
    • 6.4.2 By Product
    • 6.4.3 China
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 India
    • 6.4.7 Australia
    • 6.4.8 South East Asia
    • 6.4.9 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Technology
    • 6.5.2 By Product
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Technology
    • 6.6.2 By Product
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BLOOD SCREENING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Grifols
    • 8.2.2 Abbott
    • 8.2.3 Roche Diagnostics
    • 8.2.4 Danaher
    • 8.2.5 Bio-Rad Laboratories
    • 8.2.6 DiaSorin
    • 8.2.7 Siemens Healthineers
    • 8.2.8 Thermo Fisher Scientific
    • 8.2.9 Hologic
    • 8.2.10 BioMerieux
    • 8.2.11 Ortho Clinical Diagnostics
    • 8.2.12 Fujirebio
    • 8.2.13 Sysmex
    • 8.2.14 Werfen
    • 8.2.15 Beckman Coulter
    • 8.2.16 Becton Dickinson
    • 8.2.17 QuidelOrtho
    • 8.2.18 Meridian Bioscience
    • 8.2.19 Luminex
    • 8.2.20 Gen-Probe